Study supports more aggressive blood pressure treatment targets, US officials sayBMJ 2015; 351 doi: https://doi.org/10.1136/bmj.h4920 (Published 14 September 2015) Cite this as: BMJ 2015;351:h4920
- Michael McCarthy
US health officials have halted a large hypertension treatment trial ahead of schedule after finding strong evidence to support more aggressive treatment of high blood pressure. Initially, the trial, called the Systolic Blood Pressure Intervention Trial (SPRINT), was expected to be completed in 2017.
Officials said on 9 September that they decided to halt the study after an interim analysis of the data indicated that treating patients to achieve a target systolic blood …